Advanced Enzyme Technologies
ADVENZYMES · Pharma > Pharmaceuticals & Drugs · Chairman: Vasant Rathi Listing date: Aug. 2, 2016 · Employees: 750 · Thane · http://www.advancedenzymes.com

Stock Price vs Company Growth
1d
1.2%
1w
1.5%
1m
8.3%
3m
21.1%
6m
22.0%
1y
47.9%
5y
22.7%
all
7.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

402 1.2%
325
425
Company Overview

Sales
605 Cr
Growth: 10.8%
Profit after Tax
137 Cr
Growth: 9.9%
Small Cap
4,501 Cr
P/E: 32.8x
Industry P/E: 34.3x
Fundamentals

Sales (Cr) ₹ 605
Growth 10.8%
EBITDA 32.0%
P/S 7.4x
Dividend 0.4%
P/E 32.8x
Book Value ₹ 120
PEG Ratio 3.1x
ROE 10.7%
P/B 3.4x
Shareholding Pattern

Institutions
Orbimed Asia Iii Mauritius Limited
9.89 %
Nalanda India Equity Fund Limited
4.74 %
Hdfc Small Cap Fund
4.39 %
Orbimed Asia Iii Mauritius Fvci Limited
2.2 %
Icici Prudential Esg Fund
2.14 %
Promoters
Vasant Rathi
32.72 %
Advanced Vital Enzymes Private Limited
8.91 %
Reshma Namita Rathi
2.37 %
Rasika Vasant Rathi
2.36 %
Rachana Vasant Rathi
2.36 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes.
Investors (84)
Followers (13)